MYH9-macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26949. Epub 2017 Dec 29.

Abstract

MYH9-related disease is a rare cause of thrombocytopenia. We report an infant girl who presented with severe thrombocytopenia at birth and was initially diagnosed with and treated for neonatal alloimmune thrombocytopenia. However, persistent thrombocytopenia led to the suspicion of congenital thrombocytopenia and subsequent identification of a novel variant in MYH9 (E1421K). In silico analysis strongly predicts that this is a disruptive substitution. Immunofluorescent analysis of neutrophils demonstrates abnormal aggregates of MYH9 protein. This case also suggests that a very high immature platelet fraction (≥40%) may be useful for rapidly differentiating MYH9-related disease from other causes of neonatal thrombocytopenia.

Keywords: MYH9-macrothrombocytopenia; immature platelet fraction; neonatal alloimmune thrombocytopenia (NAIT).

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Substitution
  • Blood Platelets / metabolism
  • Blood Platelets / pathology
  • Female
  • Genetic Diseases, Inborn / blood
  • Genetic Diseases, Inborn / genetics
  • Genetic Diseases, Inborn / pathology
  • Genetic Diseases, Inborn / therapy
  • Humans
  • Infant, Newborn
  • Molecular Motor Proteins* / genetics
  • Molecular Motor Proteins* / metabolism
  • Mutation, Missense*
  • Myosin Heavy Chains* / genetics
  • Myosin Heavy Chains* / metabolism
  • Neutrophils / metabolism
  • Neutrophils / pathology
  • Protein Aggregation, Pathological* / genetics
  • Protein Aggregation, Pathological* / metabolism
  • Protein Aggregation, Pathological* / pathology
  • Protein Aggregation, Pathological* / therapy
  • Thrombocytopenia, Neonatal Alloimmune* / blood
  • Thrombocytopenia, Neonatal Alloimmune* / genetics
  • Thrombocytopenia, Neonatal Alloimmune* / pathology
  • Thrombocytopenia, Neonatal Alloimmune* / therapy

Substances

  • MYH9 protein, human
  • Molecular Motor Proteins
  • Myosin Heavy Chains